The development of increasingly powerful models is central to the unfolding AI revolution. But this revolution has a second, ...

The World Anti-Doping Agency's 2026 List of Prohibited Substances and Methods (List) and the 2026 Monitoring Program come ...

The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.

Background—Pulmonary diffusing capacity for carbon monoxide (Dlco), alveolar capillary membrane diffusing capacity (Dm), and pulmonary capillary blood volume (Vc) are all significantly reduced after ...

Adding pirfenidone to mycophenolate mofetil shows no significant improvement in lung function compared with mycophenolate ...

As smart home technology evolves from functional integration to emotional connection, olfactory interaction is emerging as a ...

Registry analysis suggests endoscopic lung volume reduction yields similar physiologic gains across sexes, but women report ...

Here are the top 5 most-read pulmonary fibrosis articles of 2025.

The most valuable AI systems will not look dramatic. They will look ordinary. They will fade into routine decisions and ...

Precise regulation of the platform capacity/voltage of electrode materials contributes to the efficient operation of ...